USPTO serial 97287505
APRIORI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 30, 2026
- Examiner
- WHEATLEY, TRAVIS DWIGHT
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with APRIORI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cambridge, MA, US
CAMBRIDGE, MA, US
CAMBRIDGE, MA, US
CAMBRIDGE, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific or medical research use; reagents for research purposes in the field of drug discovery and development | ACTIVE | May 29, 2026 |
| 005 | Therapeutic products for the treatment of disease, namely, therapeutic pharmaceuticals for the treatment of viral diseases and infectious diseases; pharmaceutical preparations and products for the treatment of viral diseases and infectious diseases; vaccines; chemical reagents for medical purposes; diagnostic products for the diagnosis of disease or health status, namely, diagnostic preparations for medical use | ACTIVE | May 29, 2026 |
| 042 | Technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, immunology and pharmaceuticals; Software as a service (SAAS) services featuring software for data analysis in the fields of biomedical and genomic research; software as a service (SAAS) services featuring software for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; software as a service (SAAS) services featuring software for predictive analytics in the fields of biomedical and genomic research | ACTIVE | May 29, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Flagship Labs 77, Inc.
- Other trademarks owned by APRIORI BIO, INC.
- Other trademarks owned by APRIORI BIO, INC.
- Other trademarks owned by APRIORI BIO, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named APRIORI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 30, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 30, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 10, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 10, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 3, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 29, 2026 | IUAF | USE AMENDMENT FILED | — |
| May 29, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 1, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 30, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Apr 30, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 25, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 24, 2025 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 29, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 28, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 28, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 26, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 26, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 26, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 30, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 29, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 29, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 29, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 24, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 22, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 22, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 22, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 30, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 4, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 4, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 15, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 28, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 27, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 27, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 27, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 24, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 14, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 27, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 27, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 27, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 27, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 20, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 19, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 19, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 13, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 3, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |